Metabolic Pathways and Cardiovascular Unit,
GlaxoSmithKline Pharmaceuticals,
USA
Biography
Robert N Willette is from Department of Heart Failure at Glaxo SmithKline Pharmaceuticals, USA. He is the Editor-in-Chief/Editorial Board Member of many peer reviewed journals and his area of expertise credits him/her with many publications in national and international journals. He is committed to highest standards of excellence and it proves through his/her authorship of many books.
Research Interest
TRPV4, Magnetic resonance imaging (MRI), Myocardial infarction, Cardiac function,Pulmonary edema, Hypertension, cardiac Function
+44 1300 500008